Equities researchers at StockNews.com started coverage on shares of United-Guardian (NASDAQ:UG – Get Free Report) in a report issued on Sunday. The brokerage set a “buy” rating on the stock.
United-Guardian Stock Up 0.9 %
Shares of NASDAQ UG opened at $9.15 on Friday. United-Guardian has a 52-week low of $5.79 and a 52-week high of $9.64. The stock has a market capitalization of $42.04 million, a PE ratio of 15.25 and a beta of 0.77. The firm has a fifty day moving average of $8.69 and a 200-day moving average of $8.21.
United-Guardian (NASDAQ:UG – Get Free Report) last announced its quarterly earnings results on Friday, May 10th. The company reported $0.20 EPS for the quarter. The company had revenue of $3.26 million during the quarter. United-Guardian had a return on equity of 25.18% and a net margin of 23.77%.
Institutional Investors Weigh In On United-Guardian
About United-Guardian
United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.
See Also
- Five stocks we like better than United-Guardian
- When to Sell a Stock for Profit or Loss
- McDonald’s Stock: Balancing Value and Innovation
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 6/17 – 6/21
- Are Penny Stocks a Good Fit for Your Portfolio?
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.